Ali, NasloonChen, StephanieTran, Trung NCook, BillAltraja, AlanBourdin, ArnaudSheu, Chau-ChyunTsai, Ming-JuHoyte, Flavia C LQuinton, AnnaEmmanuel, BenjaminGoh, Celine Y.Y.Carter, VictoriaPrice, David2024-03-152024-03-152022-10Ali, N, Chen, S, Tran, T N, Cook, B, Altraja, A, Bourdin, A, Sheu, C-C, Tsai, M-J, Hoyte, F C L, Quinton, A, Emmanuel, B, Goh, C Y Y, Carter, V & Price, D 2022, 'Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy : results from the CLEAR study', Chest, vol. 162, no. 4, Supplement, pp. A23-A27. https://doi.org/10.1016/j.chest.2022.08.0190012-3692RIS: urn:5B299337B85A3F282CF0E6930F86FDB6RIS: urn:5B299337B85A3F282CF0E6930F86FDB6https://hdl.handle.net/2164/23031Funding This study was funded by AstraZeneca. The International Severe Asthma Registry is jointly funded by Optimum Patient Care Global and AstraZeneca. Acknowledgments Medical writing support was provided by Madeleine Wynn, MRes, of PharmaGenesis London, London, UK, with funding from AstraZeneca.101786engR MedicineRJournal item10.1016/j.chest.2022.08.0191624